Pulmonary epithelioid hemangioendothelioma

Pulmonary epithelioid hemangioendothelioma (PEH), previously known as "intravascular bronchoalveolar tumor," is a rare vascular malignancy with an unpredictable prognosis. Treatment can vary from observation in asymptomatic patients to surgery in patients with resectable disease or chemoth...

Full description

Saved in:
Bibliographic Details
Published inThe Israel Medical Association journal Vol. 13; no. 11; pp. 676 - 679
Main Authors Rosengarten, Dror, Kramer, Mordechai R, Amir, Gail, Fuks, Leonardo, Berkman, Neville
Format Journal Article
LanguageEnglish
Published Israel 01.11.2011
Subjects
Antibiotics, Antineoplastic - therapeutic use
Antineoplastic Agents - therapeutic use
Biopsy
Doxorubicin - therapeutic use
Fatal Outcome
Female
Follow-Up Studies
Hemangioendothelioma, Epithelioid - diagnostic imaging
Hemangioendothelioma, Epithelioid - drug therapy
Hemangioendothelioma, Epithelioid - pathology
Humans
Interferons - therapeutic use
Lung - diagnostic imaging
Lung - ultrastructure
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - drug therapy
Lung Neoplasms - pathology
Male
Middle Aged
Tomography, X-Ray Computed
Online AccessGet full text

Cover

More Information
Summary:Pulmonary epithelioid hemangioendothelioma (PEH), previously known as "intravascular bronchoalveolar tumor," is a rare vascular malignancy with an unpredictable prognosis. Treatment can vary from observation in asymptomatic patients to surgery in patients with resectable disease or chemotherapy in patients with disseminated disease. This report describes the clinical, radiological and pathological features of three cases of PEH and a review of the current literature.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1565-1088